<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Lamm Lohmann | Activity</title>
	<link>https://recash.wpsoul.net/members/hiptaste65/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/hiptaste65/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lamm Lohmann.</description>
	<lastBuildDate>Tue, 19 May 2026 17:08:40 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">02967c4923c2f9c212ced85da2c71f42</guid>
				<title>Lamm Lohmann posted an update: Background Venous thromboembolism (VTE) is highly prevalent [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/57663/</link>
				<pubDate>Thu, 12 Dec 2024 08:06:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>Background Venous thromboembolism (VTE) is highly prevalent in cancer patients. Recent guidelines recommend considering direct oral anticoagulants (DOACs) for the treatment of cancer-associated thrombosis (CAT). However, direct head-to-head comparisons among DOACs are lacking, and almost no net clinical benefit (NCB) analysis has been performed in&hellip;<span class="activity-read-more" id="activity-read-more-57663"><a href="https://recash.wpsoul.net/activity/p/57663/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">79e8f0b8eeca07ca4202e33c262afb8a</guid>
				<title>Lamm Lohmann posted an update: Decisions to treat unruptured intracranial aneurysms remain [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/55390/</link>
				<pubDate>Wed, 11 Dec 2024 22:17:26 +0000</pubDate>

									<content:encoded><![CDATA[<p>Decisions to treat unruptured intracranial aneurysms remain challenging, as the risk of rupture needs to be balanced with risk of intervention. In 2015, the Unruptured Intracranial Aneurysm Treatment Score (UIATS) was introduced to assist physicians in the decision making process. As its reliability is still debated, we retrospectively applied&hellip;<span class="activity-read-more" id="activity-read-more-55390"><a href="https://recash.wpsoul.net/activity/p/55390/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1ffad92f080903b71d5eaa47301bbfa2</guid>
				<title>Lamm Lohmann became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/55233/</link>
				<pubDate>Wed, 11 Dec 2024 22:07:07 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>